Regulatory trial for selumetinib in children with symptomatic plexiform neurofibromas

syn58211567

Created By NF Service nf-osi-service

studyName: Regulatory trial for selumetinib in children with symptomatic plexiform neurofibromas
dataStatus: Data Not Expected
initiative: Partnership
studyLeads: Brian Weiss Michael Fisher
studyStatus: Completed
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1577750400000
institutions: Children's Hospital of Philadelphia
fundingAgency: NTAP
manifestation: Plexiform Neurofibroma
embargoEndDate: 1625011200000
grantStartDate: 1472601600000
studyFileviewId: syn58211645
syn58211645

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Regulatory trial for selumetinib in children with symptomatic plexiform neurofibromas

syn58211567

Drop files to upload

Regulatory trial for selumetinib in children with symptomatic plexiform neurofibromas page is loading…